- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
该股处于空头行情中，可能有短期反弹。
- 中期趋势：
下跌有所减缓，仍应保持谨慎。
- 长期趋势：
已有492家主力机构披露2025-06-30报告期持股数据，持仓量总计3.86亿股，占流通A股59.87%
- 波段诊断：
-
技术面诊股
诊断结果：4.9技术面打败了29%的股票
技术面评分前10的股票
近期的平均成本为49.67元。空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
平均成本
近期的平均成本为49.67元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"49.67","date":1756799462,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑输大盘，跑赢行业平均水平。
[{"date":"2025.09.03","stock":"-2.15","trade":"-1.55","ind":"-0.65"},{"date":"2025.09.02","stock":"-0.44","trade":"-1.12","ind":"-2.14"},{"date":"2025.09.01","stock":"-0.10","trade":"1.10","ind":"1.05"},{"date":"2025.08.29","stock":"1.97","trade":"-0.16","ind":"0.99"},{"date":"2025.08.28","stock":"-0.63","trade":"-0.71","ind":"2.25"},{"date":"2025.08.27","stock":"-1.44","trade":"-2.68","ind":"-1.43"},{"date":"2025.08.26","stock":"-0.92","trade":"-0.03","ind":"0.26"},{"date":"2025.08.25","stock":"0.50","trade":"0.83","ind":"2.26"},{"date":"2025.08.22","stock":"2.03","trade":"-0.41","ind":"2.07"},{"date":"2025.08.21","stock":"0.63","trade":"-0.21","ind":"-0.06"},{"date":"2025.08.20","stock":"0.26","trade":"0.26","ind":"0.89"},{"date":"2025.08.19","stock":"0.56","trade":"1.38","ind":"-0.12"},{"date":"2025.08.18","stock":"0.14","trade":"1.43","ind":"1.73"},{"date":"2025.08.15","stock":"0.28","trade":"1.01","ind":"1.60"},{"date":"2025.08.14","stock":"-0.79","trade":"-1.00","ind":"-0.87"},{"date":"2025.08.13","stock":"-0.69","trade":"-0.20","ind":"1.76"},{"date":"2025.08.12","stock":"-0.64","trade":"-0.53","ind":"0.53"},{"date":"2025.08.11","stock":"0.33","trade":"1.43","ind":"1.46"},{"date":"2025.08.08","stock":"-0.33","trade":"0.47","ind":"-0.26"},{"date":"2025.08.07","stock":"-0.06","trade":"-0.92","ind":"-0.18"},{"date":"2025.08.06","stock":"-0.68","trade":"-1.93","ind":"0.64"}]
东阿阿胶,深证成指,中药指数
压力支撑
该股压力位为49.62元，支撑位为48.89元。
[{"text":"\u538b\u529b\u4f4d","value":"49.62","date":1756828800,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"48.89","date":1756828800,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：1.4资金面打败了0%的股票
主力控盘前10的股票
行业资金
中药行业， 近5日资金流出较多，不建议投资者关注该行业的个股。
更新时间：09月03日 20:30
| 机构今日流向(万元) | -3566.63 | 机构5日流向(万元) | -12526.19 |
| 机构10日流向(万元) | -28777.39 | 机构20日流向(万元) | -44518.88 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量减少3326.26万股，其中基金净减仓146家，主力净减仓98家，请投资者中长期谨慎为宜。
截止2025-06-30，共492家主力机构（基金487家，一般法人5家），持仓量总计38555.67万股，占流通A股59.87%
其中，基金持仓与2024-12-31相比：
增仓：78家 ，增持 1533.35万股
减仓：224家 ，减持 3879.35万股
新出现在主力名单中：162家 ，持有2683.21万股
从主力名单中消失：260家 ，原持有3749.67万股
其中，基金持仓与2024-12-31相比：
增仓：78家 ，增持 1533.35万股
减仓：224家 ，减持 3879.35万股
新出现在主力名单中：162家 ，持有2683.21万股
从主力名单中消失：260家 ，原持有3749.67万股
消息面诊股
诊断结果：6.6消息面打败了77%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 东阿阿胶：9月2日获融资买入6557.80万元
2025-09-03 - 159个药品爆火！12亿中成药稳坐销冠，“神药”大
2025-09-02 - 国金证券：终端需求逐步复苏 医药健康行业景气度有望
2025-09-02 - 东阿阿胶：9月1日获融资买入6499.11万元
2025-09-02 - 405家医药公司业绩大比拼，创新药、CXO、科研服
2025-09-01 - 东阿阿胶（截止2025年8月29日）股东人数为85
2025-09-01 - 东阿阿胶：公司将综合评估审慎决策系统做好包括稳定高
2025-09-01 - 重点增持艾力斯 葛兰：继续聚焦创新药投资机会
2025-09-01 - A股分红模范生：东阿阿胶累计分红超百亿元
2025-09-01 - 东阿阿胶：8月29日获融资买入4367.11万元，
2025-09-01
消息列表
| 利好 | 分红转增 | 10派12.700919元(含税) | 2025-08-22 |
| 一般消息 | 重大事项 | 关联交易 | 2025-07-18 |
| 一般消息 | 重大事项 | 关联交易 | 2025-05-21 |
| 一般消息 | 股东大会 | 年度股东大会 | 2025-04-28 |
| 利好 | 分红转增 | 10派12.729896元(含税) | 2025-03-18 |
| 一般消息 | 重大事项 | 关联交易 | 2025-03-18 |
| 一般消息 | 高管变动 | 由于工作变动原因 | 2025-02-25 |
| 利好 | 业绩预告 | 业绩预增 | 2025-01-18 |
| 一般消息 | 高管变动 | 工作变动 | 2024-11-08 |
| 一般消息 | 高管变动 | 工作变动原因 | 2024-10-22 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 3条 | 0条 | 3条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：5.2行业面打败了69%的股票
中药行业最新资金流向
近10日来该行业走势不明显，明显跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，明显跑输大盘。
[{"date":"2025.09.03","price":"-0.65","value":"-1.55"},{"date":"2025.09.02","price":"-2.14","value":"-1.12"},{"date":"2025.09.01","price":"1.05","value":"1.10"},{"date":"2025.08.29","price":"0.99","value":"-0.16"},{"date":"2025.08.28","price":"2.25","value":"-0.71"},{"date":"2025.08.27","price":"-1.43","value":"-2.68"},{"date":"2025.08.26","price":"0.26","value":"-0.03"},{"date":"2025.08.25","price":"2.26","value":"0.83"},{"date":"2025.08.22","price":"2.07","value":"-0.41"},{"date":"2025.08.21","price":"-0.06","value":"-0.21"},{"date":"2025.08.20","price":"0.89","value":"0.26"},{"date":"2025.08.19","price":"-0.12","value":"1.38"},{"date":"2025.08.18","price":"1.73","value":"1.43"},{"date":"2025.08.15","price":"1.60","value":"1.01"},{"date":"2025.08.14","price":"-0.87","value":"-1.00"},{"date":"2025.08.13","price":"1.76","value":"-0.20"},{"date":"2025.08.12","price":"0.53","value":"-0.53"},{"date":"2025.08.11","price":"1.46","value":"1.43"},{"date":"2025.08.08","price":"-0.26","value":"0.47"},{"date":"2025.08.07","price":"-0.18","value":"-0.92"},{"date":"2025.08.06","price":"0.64","value":"-1.93"}]
深证成指,中药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | ST香雪 | 38.53% | -4.96% | 3.8分 |
| 2 | 万邦德 | 30.94% | 0.73% | 5.8分 |
| 3 | 天目药业 | 25.83% | -4.39% | 5.8分 |
| 4 | 达仁堂 | 10.59% | 4.17% | 5.0分 |
| 5 | 仁和药业 | 9.98% | 1.91% | 5.5分 |
| 6 | 振东制药 | 8.74% | -6.81% | 4.6分 |
| 8 | 云南白药 | 6.20% | 4.45% | 6.4分 |
| 10 | 步长制药 | 5.24% | 0.58% | 5.8分 |
| 12 | 方盛制药 | 3.08% | -2.90% | 5.0分 |
| 14 | 益佰制药 | 2.38% | -3.37% | 5.3分 |
| 16 | 片仔癀 | 1.43% | -1.74% | 5.4分 |
| 18 | 健民集团 | 0.89% | 2.14% | 5.6分 |
| 20 | 康惠制药 | -0.30% | -1.53% | 4.3分 |
| 22 | 天士力 | -0.61% | -2.45% | 5.2分 |
| 24 | 汉森制药 | -1.02% | 2.11% | 5.3分 |
| 26 | 康美药业 | -1.44% | -0.49% | 4.9分 |
| 28 | 东阿阿胶 | -1.56% | -1.36% | 4.9分 |
| 30 | 信邦制药 | -2.95% | -1.90% | 5.3分 |
| 32 | 康缘药业 | -3.22% | -5.00% | 4.6分 |
| 34 | 康恩贝 | -3.46% | -1.98% | 5.0分 |
| 36 | 昆药集团 | -3.63% | -2.56% | 4.6分 |
| 38 | 葵花药业 | -4.01% | -2.94% | 4.5分 |
| 40 | 九芝堂 | -4.37% | -4.87% | 5.1分 |
| 42 | 佐力药业 | -4.55% | -4.65% | 4.6分 |
| 44 | *ST长药 | -5.16% | -6.05% | 3.6分 |
| 46 | 华森制药 | -5.48% | -3.07% | 5.4分 |
| 48 | 益盛药业 | -5.96% | -2.95% | 4.5分 |
| 50 | 恩威医药 | -6.26% | -5.09% | 4.8分 |
| 52 | 佛慈制药 | -6.35% | -1.10% | 4.9分 |
| 54 | 广誉远 | -6.89% | -4.29% | 5.2分 |
| 56 | 华润三九 | -7.15% | -2.34% | 5.5分 |
| 58 | 莱茵生物 | -7.39% | -6.61% | 4.8分 |
| 60 | 桂林三金 | -7.93% | -2.17% | 5.7分 |
| 62 | 中恒集团 | -8.19% | -2.54% | 4.8分 |
| 64 | 粤万年青 | -8.77% | -1.88% | 4.9分 |
| 66 | 上海凯宝 | -9.08% | -6.29% | 4.5分 |
| 68 | 亚宝药业 | -10.58% | -1.70% | 5.0分 |
| 70 | - | -21.92% | -3.26% | 分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2025-06-30 ]公司经营
盈利能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 14/112 ， 12/112。
[{"date":"2025-06-30","value":"7.93","vol":"3.94"},{"date":"2025-03-31","value":"4.04","vol":"2.20"},{"date":"2024-12-31","value":"14.81","vol":"4.81"},{"date":"2024-09-30","value":"11.17","vol":"2.92"},{"date":"2024-06-30","value":"7.05","vol":"1.58"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
7.93 | 4.04 | 14.81 | 11.17 | 7.05 |
| 行业(%) | 3.94 | 2.20 | 4.81 | 2.92 | 1.58 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"73.13","vol":"52.43"},{"date":"2025-03-31","value":"73.62","vol":"52.92"},{"date":"2024-12-31","value":"72.42","vol":"52.40"},{"date":"2024-09-30","value":"74.13","vol":"52.75"},{"date":"2024-06-30","value":"73.54","vol":"53.12"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
73.13 | 73.62 | 72.42 | 74.13 | 73.54 |
| 行业(%) | 52.43 | 52.92 | 52.40 | 52.75 | 53.12 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 9/112 ， 24/112。
[{"date":"2025-06-30","value":"11.02","vol":"-6.98"},{"date":"2025-03-31","value":"18.24","vol":"-6.63"},{"date":"2024-12-31","value":"25.57","vol":"-6.97"},{"date":"2024-09-30","value":"26.28","vol":"-4.57"},{"date":"2024-06-30","value":"26.80","vol":"-4.39"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
11.02 | 18.24 | 25.57 | 26.28 | 26.80 |
| 行业(%) | -6.98 | -6.63 | -6.97 | -4.57 | -4.39 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"10.74","vol":"2.33"},{"date":"2025-03-31","value":"20.25","vol":"-36.42"},{"date":"2024-12-31","value":"35.29","vol":"-142.71"},{"date":"2024-09-30","value":"47.00","vol":"63.06"},{"date":"2024-06-30","value":"39.03","vol":"-13.81"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
10.74 | 20.25 | 35.29 | 47.00 | 39.03 |
| 行业(%) | 2.33 | -36.42 | -142.71 | 63.06 | -13.81 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 32/112 ， 41/112。
[{"date":"2025-06-30","value":"0.24","vol":"0.24"},{"date":"2025-03-31","value":"0.13","vol":"0.12"},{"date":"2024-12-31","value":"0.45","vol":"0.49"},{"date":"2024-09-30","value":"0.33","vol":"0.37"},{"date":"2024-06-30","value":"0.21","vol":"0.26"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.24 | 0.13 | 0.45 | 0.33 | 0.21 |
| 行业(次) | 0.24 | 0.12 | 0.49 | 0.37 | 0.26 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.89","vol":"1.17"},{"date":"2025-03-31","value":"0.48","vol":"0.60"},{"date":"2024-12-31","value":"1.68","vol":"2.40"},{"date":"2024-09-30","value":"1.22","vol":"1.79"},{"date":"2024-06-30","value":"0.74","vol":"1.23"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.89 | 0.48 | 1.68 | 1.22 | 0.74 |
| 行业(次) | 1.17 | 0.60 | 2.40 | 1.79 | 1.23 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 3/112 ， 16/112。
[{"date":"2025-06-30","value":"95.30","vol":"20.17"},{"date":"2025-03-31","value":"-17.70","vol":"0.38"},{"date":"2024-12-31","value":"45.83","vol":"15.45"},{"date":"2024-09-30","value":"32.84","vol":"6.15"},{"date":"2024-06-30","value":"21.91","vol":"11.77"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 95.30 | -17.70 | 45.83 | 32.84 | 21.91 |
| 行业 | 20.17 | 0.38 | 15.45 | 6.15 | 11.77 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.28","vol":"1.02"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"0.62","vol":"1.46"},{"date":"2024-09-30","value":"","vol":"0.00"},{"date":"2024-06-30","value":"0.53","vol":"1.40"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | 0.28 | - | 0.62 | - | 0.53 |
| 行业 | 1.02 | 0.00 | 1.46 | 0.00 | 1.40 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 60/112 ， 62/112。
[{"date":"2025-06-30","value":"4.35","vol":"2.88"},{"date":"2025-03-31","value":"4.38","vol":"2.97"},{"date":"2024-12-31","value":"3.95","vol":"2.86"},{"date":"2024-09-30","value":"3.76","vol":"3.22"},{"date":"2024-06-30","value":"4.65","vol":"2.95"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 流动比率 |
4.35 | 4.38 | 3.95 | 3.76 | 4.65 |
| 行业 | 2.88 | 2.97 | 2.86 | 3.22 | 2.95 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"3.93","vol":"2.11"},{"date":"2025-03-31","value":"3.97","vol":"2.20"},{"date":"2024-12-31","value":"3.58","vol":"2.09"},{"date":"2024-09-30","value":"3.43","vol":"2.40"},{"date":"2024-06-30","value":"4.18","vol":"2.22"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 速动比率 |
3.93 | 3.97 | 3.58 | 3.43 | 4.18 |
| 行业 | 2.11 | 2.20 | 2.09 | 2.40 | 2.22 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 52/112 ， 53/112。
[{"date":"2025-06-30","value":"19.17","vol":"33.91"},{"date":"2025-03-31","value":"19.17","vol":"33.34"},{"date":"2024-12-31","value":"21.05","vol":"34.08"},{"date":"2024-09-30","value":"21.88","vol":"32.93"},{"date":"2024-06-30","value":"17.95","vol":"33.75"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
19.17 | 19.17 | 21.05 | 21.88 | 17.95 |
| 行业(%) | 33.91 | 33.34 | 34.08 | 32.93 | 33.75 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.24","vol":"0.74"},{"date":"2025-03-31","value":"0.24","vol":"0.72"},{"date":"2024-12-31","value":"0.27","vol":"0.74"},{"date":"2024-09-30","value":"0.28","vol":"3.16"},{"date":"2024-06-30","value":"0.22","vol":"1.63"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.24 | 0.24 | 0.27 | 0.28 | 0.22 |
| 行业(%) | 0.74 | 0.72 | 0.74 | 3.16 | 1.63 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 浙商证券 | 2025-08-27 | 买入 | |
| 中信证券 | 2025-08-27 | 买入 | |
| 华创证券 | 2025-08-26 | 增持 | |
| 长江证券 | 2025-08-25 | 买入 | |
| 华泰证券 | 2025-08-24 | 增持 | |
| 中泰证券 | 2025-08-24 | 买入 |
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"4.40","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"7.80","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"11.51","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"15.57","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"18.36","blueLineValue":"2.85","type":"YC"}]